Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Citius Pharmaceuticals In...

    NASDAQ: CTXR · Real-Time Price · USD
    2.21
    0.11 (5.24%)
    At close: Jul 03, 2025, 3:57 PM
    2.25
    1.81%
    After-hours: Jul 03, 2025, 04:58 PM EDT

    Citius Pharmaceuticals Statistics

    Share Statistics

    Citius Pharmaceuticals has 11.17M shares outstanding. The number of shares has increased by -93.82% in one year.

    Shares Outstanding

    n/a
    		 11.17M

    Shares Change (YoY)

    n/a
    		 -93.82%

    Shares Change (QoQ)

    n/a
    		 30.04%

    Owned by Institutions (%)

    n/a
    		 0.04%

    Shares Floating

    n/a
    		 10.53M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,561

    FTD / Avg. Volume

    n/a
    		 0.13%

    Short Selling Information

    The latest short interest is 1.35M, so 12.45% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.35M

    Short % of Shares Out

    n/a
    		 12.45%

    Short % of Float

    n/a
    		 13.04%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -3.68 and the forward PE ratio is 5.68. Citius Pharmaceuticals's PEG ratio is -0.81.

    PE Ratio

    n/a
    		 -3.68

    Forward PE

    n/a
    		 5.68

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 2.07

    P/FCF Ratio

    n/a
    		 -5.15

    PEG Ratio

    n/a
    		 -0.81
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Citius Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.4, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.4

    Quick Ratio

    n/a
    		 0.17

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,714,166.91

    Employee Count

    n/a
    		 23

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 0.03

    Taxes

    Income Tax

    n/a
    		 576K

    Effective Tax Rate

    n/a
    		 -1.48%

    Stock Price Statistics

    The stock price has increased by -81.8% in the last 52 weeks. The beta is 0.85, so Citius Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.85

    52-Week Price Change

    n/a
    		 -81.8%

    50-Day Moving Average

    n/a
    		 0.96

    200-Day Moving Average

    n/a
    		 3.91

    Relative Strength Index (RSI)

    n/a
    		 79.62

    Average Volume (20 Days)

    n/a
    		 2,720,404

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -42M

    Net Income

    n/a
    		 -39.43M

    EBITDA

    n/a
    		 -38.64M

    EBIT

    n/a
    		 -38.85M

    Earnings Per Share (EPS)

    n/a
    		 -0.23
    Full Income Statement

    Balance Sheet

    The company has 3.25M in cash and 262.87K in debt, giving a net cash position of 2.99M.

    Cash & Cash Equivalents

    n/a
    		 3.25M

    Total Debt

    n/a
    		 262.87K

    Net Cash

    n/a
    		 2.99M

    Retained Earnings

    n/a
    		 -201.37M

    Total Assets

    n/a
    		 121.48M

    Working Capital

    n/a
    		 -31.5M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -28.2M and capital expenditures 0, giving a free cash flow of -28.2M.

    Operating Cash Flow

    n/a
    		 -28.2M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -28.2M

    FCF Per Share

    n/a
    		 -2.43
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CTXR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CTXR is $54.5, which is 2366.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $54.5

    Price Target Difference

    n/a
    		 2366.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 9, 2017. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Jun 9, 2017

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -3.59

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist